WAYLAND GROUP CORP ORDINARY SHARES (OTCMKTS:MRRCF) Could Improve Your Long Portfolio After Less Shorts Reported

The stock of WAYLAND GROUP CORP ORDINARY SHARES (OTCMKTS:MRRCF) registered a decrease of 70.76% in short interest. MRRCF’s total short interest was 66,000 shares in March as published by FINRA. Its down 70.76% from 225,700 shares, reported previously. With 404,400 shares average volume, it will take short sellers 0 days to cover their MRRCF’s short positions.

The stock increased 4.22% or $0.0293 during the last trading session, reaching $0.723. About 138,019 shares traded. Wayland Group Corp. (OTCMKTS:MRRCF) has 0.00% since March 17, 2018 and is . It has underperformed by 4.37% the S&P500.

Maricann Group Inc. produces and distributes marijuana for medical purposes. The company has market cap of $159.20 million. The firm offers dried marijuana, cannabis oil, and gums. It currently has negative earnings. It also provides accessories, including vaporizers, grinders, and other paraphernalia.

More notable recent Wayland Group Corp. (OTCMKTS:MRRCF) news were published by: Midasletter.com which released: “Asia’s Emerging Cannabis Markets with Deepak Anand – Midas Letter” on January 23, 2019, also Globenewswire.com with their article: “Maricann Group Announces Closing of Haxxon Acquisition Canadian Stock Exchange:WAYL.CN – GlobeNewswire” published on May 10, 2018, Midasletter.com published: “Dmitry Zaytsev Examines Latest Aphria Inc (TSE:APHA) Financials, Management Changes – Midas Letter” on January 22, 2019. More interesting news about Wayland Group Corp. (OTCMKTS:MRRCF) were released by: Midasletter.com and their article: “AltaCorp Capital Managing Director on Flourishing Cannabis Pharma Space – Midas Letter” published on January 16, 2019 as well as Seekingalpha.com‘s news article titled: “Weed Inc. Is Overvalued And Lost 666% More In The Nine Months Ended September 2018 – Seeking Alpha” with publication date: January 07, 2019.

Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our FREE daily email newsletter.